To include your compound in the COVID-19 Resource Center, submit it here.

Lymphoseek tilmanocept regulatory update

Navidea said FDA granted Orphan Drug status for Lymphoseek tilmanocept to detect sentinel lymph nodes in patients with cancer of

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE